Drug | Tablet
Glimepiride (1 mg) + Metformin + Voglibose (0.3 mg)
controls blood sugar levels, improves insulin sensitivity, reduces postprandial glucose levels
Sulfonylurea that stimulates pancreatic insulin release and improves sensitivity.; Decreases hepatic glucose production and improves insulin sensitivity; acts in liver and gut.
Take with meals, monitor blood sugar regularly, avoid alcohol consumption
Common side effects of Glycomet Trio 1/0.3 Tablet may include:
Carry sugar source for hypoglycemia; review during illness or fasting.; Inform clinician about kidney problems; withhold around iodinated contrast when advised.
